Dr TV Patel Eye Insititute
Vadodara, Gujarat, 390001, India
NCT Number: NCT01995890
The Nevanac product information insert says that it can cause increase in eye pressure in 5-10% of patients. There is very little published literature on the effect of topical Nepafenac eye drops on eye pressure in normal people. The purpose of our study is to report this effect with a working hypothesis that there is no increase in eye pressure following use of Nepafenac eye drops.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 4
Vadodara, Gujarat, 390001, India
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Nevanac
Time frame: 4 weeks
Intraocular pressure elevation of more than 4 mmHg from baseline
Time frame: 8 weeks
Intraocular pressure elevation of more than 4 mmHg from baseline
Dr T V Patel Eye Institute
Other
Effect of Nepafenac Eye Drops on Intraocular Pressure - a Randomized Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04281017
Intraocular Pressure, Neoplasms
Gainesville, Florida, United States
View Trial DetailsNCT07274176
Intraocular Pressure
Uşak, Turkey (Türkiye)
View Trial DetailsNCT07701278
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Banhā, Benha, Egypt
View Trial DetailsNCT07604428
Apnea, Eye Diseases
Olomouc, Czechia
View Trial Details